Among patients who received chemotherapy, exemestane plus ovarian suppression, as compared with tamoxifen plus ovarian suppression, improved the proportion of sufferers without breast cancer at 5 years by 5.5 %age factors in TEXT and by 3.9 %age factors in SOFT and the proportion of individuals without distant recurrence at 5 years by 2.6 %age points in TEXT and by 3.4 %age factors in SOFT . Although there was no significant difference in overall survival according to randomized treatment, conclusions are premature at 68 months of follow-up in this individual population.Companies would be smart to ensure their products are represented within Wikipedia entries over the various countries adequately, and to also study condition-particular treatment entries to certify that available options are presented accurately and totally. Of course, as some companies have learned – be vigilant in how you approach altering or editing Wikipedia content online. Ensuring complete content is one thing but selective removal of content is clearly another. Additionally, given this dearth of country-particular health content in lots of European countries, companies can fill up the gap of unmet demand by providing disease education content on-line.